Related references
Note: Only part of the references are listed.SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor gamma in C2C12 myotubes
Sung Soo Chung et al.
BIOCHEMICAL JOURNAL (2011)
An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high-saturated fat
Tomomi Yamazaki et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Jang Hyun Choi et al.
NATURE (2010)
Effect of a peroxisome proliferator-activated receptor γ sumoylation mutant on neointimal formation after balloon injury in rats
Soo Lim et al.
ATHEROSCLEROSIS (2009)
Glutathione Peroxidase 3 Mediates the Antioxidant Effect of Peroxisome Proliferator-Activated Receptor gamma in Human Skeletal Muscle Cells
Sung Soo Chung et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Frederic Colland et al.
MOLECULAR CANCER THERAPEUTICS (2009)
PPAR-γ AF-2 Domain Functions as a Component of a Ubiquitin-dependent Degradation Signal
Gail E. Kilroy et al.
OBESITY (2009)
Posttranslational Modifications of PPAR-γ: Fine-tuning the Metabolic Master Regulator
Olivier van Beekum et al.
OBESITY (2009)
Sumoylation of peroxisome proliferator-activated receptor γ by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from κB binding sites proinflammatory cytokines
Carla Jennewein et al.
JOURNAL OF IMMUNOLOGY (2008)
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Min Sup Song et al.
NATURE (2008)
Stearoyl-CoA desaturase 2 is required for peroxisome proliferator-activated receptor γ expression and adipogenesis in cultured 3T3-L1 cells
Jennifer L. Christianson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP
Armando van der Horst et al.
NATURE CELL BIOLOGY (2006)
Peroxisome proliferator-activated receptor γ recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis
Irena Iankova et al.
MOLECULAR ENDOCRINOLOGY (2006)
PPAR-γ ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells
Nomeli P. Nunez et al.
CANCER LETTERS (2006)
Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: Implications for the regulation of the p53-MDM2 pathway
M Hu et al.
PLOS BIOLOGY (2006)
Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus
K Nagashima et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1: Implications for EBV-mediated immortalization
V Saridakis et al.
MOLECULAR CELL (2005)
Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway
ET Kase et al.
DIABETES (2005)
GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7
JA van der Knaap et al.
MOLECULAR CELL (2005)
A dynamic role of HAUSP in the p53-Mdm2 pathway
MY Li et al.
MOLECULAR CELL (2004)
Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer
VG Keshamouni et al.
ONCOGENE (2004)
Transcriptional activity of peroxisome proliferator-activated receptor γ is modulated by SUMO-1 modification
T Ohshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes
K Matsusue et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
PPAR-γ activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity -: Mechanisms for modulation of postprandial lipemia and differential adipose accretion
M Laplante et al.
DIABETES (2003)
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
MY Li et al.
NATURE (2002)
Interferon-γ-mediated activation and ubiquitin-proteasome-dependent degradation of PPARγ in adipocytes
ZE Floyd et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones
M Bedoucha et al.
JOURNAL OF HEPATOLOGY (2001)
Interferon-γ-induced regulation of peroxisome proliferator-activated receptor γ and STATs in adipocytes
KJ Waite et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Hepatic over-expression of peroxisome proliferator activated receptor gamma 2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus
R Rahimian et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
A Chawla et al.
NATURE MEDICINE (2001)
Up-regulation of peroxisome proliferator-activated receptors (PPAR-α) and PPAR-γ messenger ribonucleic acid expression in the liver in murine obesity:: Troglitazone induces expression of PPAR-γ-responsive adipose tissue-specific genes in the liver of obese diabetic mice
RA Memon et al.
ENDOCRINOLOGY (2000)
Effects of ligand activation of peroxisome proliferator-activated receptor γ in human prostate cancer
E Mueller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation
S Hauser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)